By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Science Briefing
  • Medicine
  • Biology
  • Engineering
  • Environment
  • More
    • Dentistry
    • Chemistry
    • Physics
    • Agriculture
    • Business
    • Computer Science
    • Energy
    • Materials Science
    • Mathematics
    • Politics
    • Social Sciences
Notification
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Personalize
Science BriefingScience Briefing
Font ResizerAa
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Search
  • Quick Access
    • Home
    • Contact Us
    • Blog Index
    • History
    • My Saves
    • My Interests
    • My Feed
  • Categories
    • Business
    • Politics
    • Medicine
    • Biology

Top Stories

Explore the latest updated news!

A hybrid experimental and machine learning framework for designing and predicting compressive strength of ultra-high-performance concrete

Science Briefing

Science Briefing

Stay Connected

Find us on socials
248.1KFollowersLike
61.1KFollowersFollow
165KSubscribersSubscribe
Made by ThemeRuby using the Foxiz theme. Powered by WordPress

Home - Biology - Today’s Immunology Science Briefing | April 28th 2026, 9:00:12 am

Biology

Today’s Immunology Science Briefing | April 28th 2026, 9:00:12 am

Last updated: April 28, 2026 7:33 am
By
Science Briefing
ByScience Briefing
Science Communicator
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Follow:
No Comments
Share
SHARE

Key Highlights

•
Researchers have found that a protein called Folate receptor beta (FRβ) plays a surprising new role in the immune system, acting as a master switch that turns on a powerful inflammatory process known as the NLRP3 inflammasome in macrophages—key immune cells.
Source →

•
This discovery reveals that FRβ works independently of its known job of transporting folate (a vitamin), instead controlling inflammation by regulating DNA methylation and potassium flow in cells. This opens up a potential new target for therapies aimed at dampening harmful inflammation in diseases like autoimmunity and cancer.
Source →


Stay curious. Stay informed — with
Science Briefing.

Always double check the original article for accuracy.


Reset My Briefings

Share This Article
Facebook Flipboard Pinterest Whatsapp Whatsapp LinkedIn Tumblr Reddit Telegram Threads Bluesky Email Copy Link Print
Share
ByScience Briefing
Science Communicator
Follow:
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Previous Article Today’s Clinical Medicine Science Briefing | April 28th 2026, 9:00:12 am
Next Article Today’s Renewable Energy Science Briefing | April 28th 2026, 9:00:12 am
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related Stories

Uncover the stories that related to the post!

Science Briefing

Science Briefing

A new subcutaneous weapon joins the lupus armamentarium

The Protease Switch: How uPA Reshapes Immune Cell Highways

A new adaptor protein reveals the hidden mechanics of cellular lipid balance

Unlocking the Dynamic Disorder of a Key Cancer Suppressor

Drift, Not Selection, as the Architect of Norovirus Diversity

Science Briefing

Show More

Science Briefing delivers personalized, reliable summaries of new scientific papers—tailored to your field and interests—so you can stay informed without doing the heavy reading.

Science Briefing
  • Categories:
  • Medicine
  • Biology
  • Social Sciences
  • Energy
  • Gastroenterology
  • Surgery
  • Uncategorized
  • Chemistry
  • Natural Language Processing
  • Engineering

Quick Links

  • My Feed
  • My Interests
  • History
  • My Saves

About US

  • Adverts
  • Our Jobs
  • Term of Use

ScienceBriefing.com, All rights reserved.

Personalize you Briefings
To Receive Instant, personalized science updates—only on the discoveries that matter to you.
Please enable JavaScript in your browser to complete this form.
Loading
Zero Spam, Cancel, Upgrade or downgrade anytime!
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?